3.50
0.00%
0.00
Handel nachbörslich:
3.50
Schlusskurs vom Vortag:
$3.50
Offen:
$3.5
24-Stunden-Volumen:
803.54K
Relative Volume:
1.96
Marktkapitalisierung:
$423.54M
Einnahmen:
$34.16M
Nettoeinkommen (Verlust:
$-50.62M
KGV:
-21.94
EPS:
-0.1595
Netto-Cashflow:
$703.00K
1W Leistung:
-7.65%
1M Leistung:
-10.26%
6M Leistung:
-13.79%
1J Leistung:
-38.16%
Omniab Inc Stock (OABI) Company Profile
Firmenname
Omniab Inc
Sektor
Branche
Telefon
510-250-7800
Adresse
5980 HORTON STREET, EMERYVILLE
Vergleichen Sie OABI mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
OABI
Omniab Inc
|
3.50 | 423.54M | 34.16M | -50.62M | 703.00K | -0.508 |
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Omniab Inc Stock (OABI) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2023-11-29 | Eingeleitet | RBC Capital Mkts | Outperform |
2023-04-21 | Eingeleitet | The Benchmark Company | Buy |
2023-04-13 | Eingeleitet | Craig Hallum | Buy |
2023-02-22 | Eingeleitet | Cowen | Outperform |
2023-02-13 | Eingeleitet | H.C. Wainwright | Buy |
2022-12-20 | Eingeleitet | Truist | Buy |
2022-12-16 | Eingeleitet | Credit Suisse | Outperform |
2022-11-29 | Eingeleitet | SVB Leerink | Outperform |
2022-11-28 | Eingeleitet | Stifel | Buy |
Alle ansehen
Omniab Inc Aktie (OABI) Neueste Nachrichten
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $542,000 Stock Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Fmr LLC Acquires 13,324 Shares of OmniAb, Inc. (NASDAQ:OABI) - Defense World
OABI stock touches 52-week low at $3.55 amid market challenges - Investing.com
OmniAb (NASDAQ:OABI) Hits New 1-Year LowShould You Sell? - MarketBeat
OmniAb Unveils Revolutionary AI-Powered Antibody Discovery Platform, Launches Advanced OmniHub™ Portal - StockTitan
OmniAb's SWOT analysis: antibody discovery firm's stock poised for growth By Investing.com - Investing.com South Africa
OmniAb's SWOT analysis: antibody discovery firm's stock poised for growth - Investing.com India
Charles Schwab Investment Management Inc. Increases Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb (NASDAQ:OABI) Shares Down 5.5%Here's Why - MarketBeat
OmniAb CFO Kurt Gustafson sells $98,587 in stock By Investing.com - Investing.com Nigeria
OmniAb chief legal officer sells $33,130 in shares By Investing.com - Investing.com Nigeria
omniAb CEO Matthew Foehr sells $56,308 in stock By Investing.com - Investing.com Canada
omniAb CEO Matthew Foehr sells $56,308 in stock - Investing.com India
OmniAb chief legal officer sells $33,130 in shares - Investing.com India
OmniAb CFO Kurt Gustafson sells $98,587 in stock - Investing.com
First Sabrepoint Capital Management LP Sells 210,000 Shares of OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
THARTharimmune, Inc. Latest Stock News & Market Updates - StockTitan
1,000,000 Shares in OmniAb, Inc. (NASDAQ:OABI) Acquired by Murchinson Ltd. - MarketBeat
OmniAb's SWOT analysis: antibody discovery firm's stock faces growth hurdles - Investing.com
35,081 Shares in OmniAb, Inc. (NASDAQ:OABI) Bought by Atria Investments Inc - Defense World
GSA Capital Partners LLP Decreases Position in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb, Inc. (NASDAQ:OABI) Just Reported And Analysts Have Been Cutting Their Estimates - Yahoo Finance
Janus Henderson Group PLC's Strategic Acquisition in OmniAb Inc - GuruFocus.com
OmniAb, Inc. (OABI) Reports Q3 Loss, Lags Revenue Estimates - MSN
Benchmark Reiterates "Buy" Rating for OmniAb (NASDAQ:OABI) - MarketBeat
OmniAb Third Quarter 2024 Earnings: Misses Expectations - Simply Wall St
OmniAb's (OABI) Buy Rating Reiterated at HC Wainwright - MarketBeat
Earnings call: OmniAb reports Q3 financials and optimistic business outlook - Investing.com
OmniAb, Inc. (NASDAQ:OABI) Q3 2024 Earnings Call Transcript - Insider Monkey
OmniAb Inc (OABI) Q3 2024 Earnings Call Highlights: Strong Program Growth Amid Revenue Challenges - Investing.com Canada
OmniAb Reports Third Quarter 2024 Financial Results - TipRanks
OmniAb Reports Third Quarter 2024 Financial Results and Business Highlights - StockTitan
OmniAb Inc (OABI) Q3 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus.com
OmniAb (OABI) Scheduled to Post Earnings on Tuesday - Defense World
Villere ST Denis J & Co. LLC Cuts Holdings in OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
Rice Hall James & Associates LLC Raises Stake in OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
OmniAb to Participate in Two Investor Conferences in November - StockTitan
Bleakley Financial Group LLC Trims Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb to Report Third Quarter 2024 Financial Results on November 12 - StockTitan
The Manufacturers Life Insurance Company Invests $147,000 in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Is OmniAb (NASDAQ:OABI) In A Good Position To Invest In Growth? - Yahoo Finance
Millennium Management LLC Reduces Stock Position in OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
Sei Investments Co. Has $109,000 Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
Dimensional Fund Advisors LP Buys 194,835 Shares of OmniAb, Inc. (NASDAQ:OABI) - MarketBeat
American Century Companies Inc. Raises Holdings in OmniAb, Inc. (NASDAQ:OABI) - Defense World
OmniAb's SWOT analysis: antibody discovery firm's stock faces pivotal 2H24 - Investing.com
OmniAb's SWOT analysis: antibody discovery firm's stock faces pivotal 2H24 By Investing.com - Investing.com UK
The Attractiveness of Investing In OmniAb Inc (OABI) is Growing - Knox Daily
Finanzdaten der Omniab Inc-Aktie (OABI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Omniab Inc-Aktie (OABI) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
FOEHR MATTHEW W | President and CEO |
Dec 09 '24 |
Sale |
4.13 |
13,634 |
56,308 |
3,714,447 |
GUSTAFSON KURT A | Executive VP, Finance and CFO |
Dec 09 '24 |
Sale |
4.13 |
23,871 |
98,587 |
200,661 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):